Surface-enhanced Raman spectroscopy (SERS), as a great potential label-free tool in metabolite detection, offers a strategy for rapid bacterial identification. However, it still lacks experimentally supported spectral interpretation at the metabolite level for complex biosamples. We present a SERS-based method for reliable bacterial intracellular metabolic profiling using plasmonic colloids with high rapidness and cost-efficiency. A convolutional neural network model was constructed to accurately classify eight types of bacteria with an overall accuracy as high as 90.44% and identify the key spectral features for classification by Shapley Additive Explanations. Molecule-level interpretation of the SERS metabolic profiles has been further realized in combination with laser desorption/ionization mass spectrometry, evidencing the primary metabolite contribution to the bacterial spectral signatures and molecule-level distinctions among different bacterial types. We provide insights into the mechanism of bacterial identification by label-free SERS and pave the way for interpretable SERS diagnostic tools for various diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: